Lead

EQS-News: Advanced Blockchain AG: Value of group’s top ten portfolio holdings increases by 45%

Retrieved on: 
水曜日, 3月 13, 2024

Total value of the group’s top ten holdings up to €57.5million (FY 2023: €39.65 million)

Key Points: 
  • Total value of the group’s top ten holdings up to €57.5million (FY 2023: €39.65 million)
    21 February 2024 – Advanced Blockchain AG (“AB”, Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect and investor for the blockchain industry, has significantly increased the value of its 2023 portfolio.
  • This corresponds to an increase of 45% compared to May 31, 2023, where the valuation was €39.65 million.
  • This underlines the continuous strategic efforts of Advanced Blockchain AG and its position as an innovation leader in the industry.
  • I am more convinced than ever that Advanced Blockchain will continue to benefit from the success of these companies and capitalize on this momentum.

EQS-News: Correction of a release from 21/02/2024, 07:29 CET/CEST - Advanced Blockchain AG: Value of group’s top ten portfolio holdings increases by 45%

Retrieved on: 
水曜日, 3月 13, 2024

Correction of a release from 21/02/2024, 07:29 CET/CEST - Advanced Blockchain AG: Value of group’s top ten portfolio holdings increases by 45%

Key Points: 
  • Correction of a release from 21/02/2024, 07:29 CET/CEST - Advanced Blockchain AG: Value of group’s top ten portfolio holdings increases by 45%
    The issuer is solely responsible for the content of this announcement.
  • The current valuation of the top ten portfolio assets by the independent appraiser AVS-Valuation GmbH resulted in a total valuation of €57.5 million as of December 31, 2023.
  • This corresponds to an increase of 45% compared to May 31, 2023, where the valuation was €39.65 million.
  • This underlines the continuous strategic efforts of Advanced Blockchain AG and its position as an innovation leader in the industry.

EQS-News: Aurubis AG: Precious metals theft: Verdict announced at Hamburg District Court

Retrieved on: 
水曜日, 3月 13, 2024

Hamburg, February 23, 2024 — The verdict was announced in the Hamburg District Court today in the Aurubis precious metals theft trial.

Key Points: 
  • Hamburg, February 23, 2024 — The verdict was announced in the Hamburg District Court today in the Aurubis precious metals theft trial.
  • Aurubis is building a new security area at its Hamburg plant that will integrate the entire precious metals processing chain.
  • The Precious Metals Refinery project in Hamburg is an important investment in the security in precious metals recovery at Aurubis.
  • Aurubis produces a number of other metals as well, including precious metals, selenium, lead, nickel, tin and zinc.

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Retrieved on: 
水曜日, 3月 6, 2024

Research Nester says , "The global pancreatic cancer market size is slated to expand at ~18% CAGR between 2024 and 2036.

Key Points: 
  • Research Nester says , "The global pancreatic cancer market size is slated to expand at ~18% CAGR between 2024 and 2036.
  • The American Cancer Society's estimates for pancreatic cancer in the United States for 2024 are: "About 66,440 people (34,530 men and 31,910 women) will be diagnosed with pancreatic cancer.
  • Pancreatic cancer accounts for about 3% of all cancers in the US and about 7% of all cancer deaths."
  • Biotech/oncology stocks targeting the growing global pancreatic cancer market have made headlines with recent developments and breakthroughs in treatments.

AliMed Unveils Proprietary Line of Radiation Protection Garments, Managing Full Manufacturing Process for Improved Quality and Timely Delivery

Retrieved on: 
火曜日, 3月 5, 2024

This line, featuring Grab 'n Go™ Aprons , Perfect Fit™ Aprons , and coordinating thyroid shields , is now exclusively manufactured by AliMed, marking the company's debut in the radiation protection manufacturing space.

Key Points: 
  • This line, featuring Grab 'n Go™ Aprons , Perfect Fit™ Aprons , and coordinating thyroid shields , is now exclusively manufactured by AliMed, marking the company's debut in the radiation protection manufacturing space.
  • With healthcare organizations facing unreliable sourcing options, poor-quality manufacturing, and long lead times, demand for high-quality, reliable radiation protection garments has intensified.
  • As a long-time medical products manufacturer, AliMed has responded by taking ownership of the manufacturing and distribution processes of its branded radiation protection line to combat third-party quality issues and roadblocks that have led to customer dissatisfaction.
  • New AliMed Radiation Protection Aprons are now exclusively manufactured by AliMed, marking the company's debut in the radiation protection manufacturing space.

ASRT SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Assertio Holdings, Inc. (ASRT)

Retrieved on: 
木曜日, 2月 29, 2024

Radnor, Pennsylvania--(Newsfile Corp. - February 29, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been against Assertio Holdings, Inc. ("Assertio") (NASDAQ: ASRT).

Key Points: 
  • Radnor, Pennsylvania--(Newsfile Corp. - February 29, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been against Assertio Holdings, Inc. ("Assertio") (NASDAQ: ASRT).
  • The action charges Assertio with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.
  • As a result of Assertio' s materially misleading statements and omissions to the public, Assertio' s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Assertio investors who have suffered significant losses to contact the firm directly to acquire more information.

Recursion Announces Plans to Open New Office in London

Retrieved on: 
月曜日, 3月 11, 2024

LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new office in London’s vibrant King’s Cross neighborhood.

Key Points: 
  • LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
  • "London stood out as an ideal location given its brilliant and interdisciplinary talent across the fields of technology, biology and chemistry.
  • Recursion’s new London office will serve as an extension of both Recursion and Valence Labs’ teams.
  • To launch recruiting efforts for the new site, Recursion has opened multiple new roles across technology and biology functions with immediate plans to hire the first 20 people to be based out of the new London office.

FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against BioNTech SE (BNTX)

Retrieved on: 
月曜日, 3月 11, 2024

The action charges BioNTech with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges BioNTech with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of BioNTech’ s materially misleading statements and omissions to the public, BioNTech’ s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages BioNTech investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Palo Alto Networks, Inc. (PANW) and Encourages Investors with Significant Losses to Contact the Firm

Retrieved on: 
月曜日, 3月 11, 2024

The action charges Palo Alto with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Palo Alto with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Palo Alto’s materially misleading statements and omissions to the public, Palo Alto’s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Palo Alto investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Palo Alto, Schlaegel v. Palo Alto Networks, Inc., et al., Case No.

Amplitude, Inc. (AMPL) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AMPL Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf

Retrieved on: 
月曜日, 3月 11, 2024

The action charges Amplitude with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Amplitude with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Amplitude’ s materially misleading statements and omissions to the public, Amplitude’ s investors have suffered significant losses.
  • Our securities fraud litigators are regularly recognized as leaders in the field as well as the firm itself which is continuously awarded for the successful results we’ve achieved.
  • Kessler Topaz Meltzer & Check, LLP encourages Amplitude investors who have suffered significant losses to contact the firm directly to acquire more information.